The Quest

LifeTec Group™’s PhysioHeart™ is an ex vivo beating heart platform based on slaughterhouse tissues, a cardiac simulator that has been used for many years in the preclinical research domain. The PhysioHeart™ can provide useful insights because it is living and contracting, under physiological pressures and flows.  So far, the PhysioHeart™ has mostly been used for structural interventions that were focussing on hemodynamic responses. Besides structural interventions, the platform has proven itself for imaging studies as well for most of the common clinical modalities you can think of: Ultrasound, CT, MRI,  Fluoroscopy and intracardiac videoscopy. Despite these many years of research, there is another area where a lot can be learned still: the electrophysiological behaviour of the heart, especially in the atria.

Given that the platform provides a living heart with full access to interact with the cardiac tissue and without concerns on animal welfare during the procedure, it can be an ideal tool to investigate electrophysiological devices and interventions. To determine how the ex-vivo electrophysiology of the heart compares to that of actual patients, we have made this one of our research goals. LifeTec Group™ has recently joined the SIGNET project to expand on our knowledge on this topic.

PhysioHeart preparation

The Project

Within SIGNET, (Sensing and Image-Guided Neurological therapies, cardiac Electrophysiology and Tumour treatments), the overall objective is to develop efficient image-guided treatment workflows to replace currently complex procedures in cardiology, oncology and neurology. The ultimate goal is to come up with single-episode, personalized, dose-adaptive, high-precision Magnetic Resonance guided treatments and interventions. These developments are aimed to improve patient comfort, safety and treatment outcome but also be more economically viable and less dependent on staff availability. For more information on the SIGNET project, please visit the project website.

PhysioHeart MRI

Cardiac Ablation

LifeTec Group™ is mainly involved in the cardiac use case: treatment of cardiac arrythmia by ablation. Cardiac arrythmia occurs when the natural electrical conductance pathway of the heart is disturbed. This results in unsynchronized contractions of the heart that lead to an inefficient heart function. The disturbance of the conductance pathway often originates at the ostia of the pulmonary veins. During ablation, tiny scars are created to block these abnormal electrical signals by advancing a catheter in the groin, up to right atrium, cross the atrial septum and then reach the target area. However, before a patient can finally receive this treatment, several hospital visits are required, multi-modality imaging and planning are required and the procedure itself can be challenging.

In SIGNET we aim to develop MR guided Electrophysiology ablation (MRgEP). During ablation procedures, besides the desired scar creation also swelling of the treated tissue occurs and this also blocks electrical signals. In some cases, the ablation procedure initially seems to have been effective, but when the tissue swelling resolves after a couple of days, the arrythmia’s return. One main advantage of using MR as a guidance technique is the ability to distinguish between scarred tissue and swollen tissue. And what better object could be used to test such a technique than LifeTec Group’s PhysioHeart?

PhysioHeart Electrophysiology

What will we do?

That’s right, in the 3 years of this project, we will transform the PhysioHeart™ into an MRI-compatible testing phantom to evaluate ablation therapy effectiveness. However, the electrophysiological behaviour of the atria in the Physioheart platform has not been researched before. This will be the start of the project: learn about the electrophysiology of the PhysioHeart platform and try to perform mapping measurements on it. Once that is achieved in our lab in Eindhoven and the healthy/reference status of the platform is known, we will transform this into an MR-compatible version and bring it to the MRI where real ablation studies will be performed and the response of our ex-viv cardiac tissue - swelling, electrophysiological patterns and resulting contractions - can be studied to learn about the energy delivery required to perform successful ablations.


What's in it for you?

If you are working in MR-guided interventional therapies or in cardiac electrophysiology therapies, we will develop great opportunities for you to investigate your new treatment concepts. The compatibility of the PhysioHeart with MR imaging will be greatly improved, which will become accessible to your project as a research platform. Moreover, a lot of knowledge on the electrophysiological behaviour of our ex-vivo model and interventions to influence this behaviour will be generated and this will open new opportunities for you to work with us. If you are interested in these developments, follow this page which will be updated throughout the project and feel free to reach out to us for more information. Our team is ready and interested in your questions!

Meeting at LifeTec Group


Pragmatic engineers: that’s what our clients, medical specialists and fellow researchers sometimes call us. We are proud of this reputation as it tells you a great deal about the company and its people